Ampligent Information

Ampligent is a strategic consulting and commercialization company that specializes in launch excellence solutions. Our focus is on pharmaceutical, biotech, and diagnostics companies developing products to address healthcare needs for patients with gastrointestinal and chronic liver disease. Ampligent is an affiliate of Focus Medical Communications and Tactical Advantage Group, companies that have developed unique relationships with Key Opinion Leader (KOL) gastroenterologists and hepatologists through the Chronic Liver Disease Foundation and the GI Health Foundation. Ampligent's principals, Steve Taglienti and Steve Petruccelli, have over 25 years' experience in pharmaceutical and biotech new product planning, business intelligence, product launch, marketing, and sales success. Our team of 40 clinical, marketing, and meeting planning professionals can support and enhance multiple new product planning and launch activities, including clinical and commercial strategic planning, KOL advisory boards, KOL and speaker identification and development, and multichannel target marketing. We are customer focused, nimble, innovative, and cost effective. We welcome the opportunity to support and enhance your new product planning and launch readiness efforts to maximize the potential of your new product.